Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double ovarian stimulation in poor ovarian responders undergoing IVF/ICSI
ChiCTR-OCH-13003992Phase 3Completed
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- Jun 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of letrozole and human menopausal gonadotrophin in poor ovarian response (POR) (2 arms), sponsored by Shanghai Ninth People's Hospital. Primary endpoint: Number of oocytes retrieved. Started Jun 2012; status: completed.
02
Drugs
letrozolehuman menopausal gonadotrophin
03
Conditions
poor ovarian response (POR)
Beyond the preview
Go deeper on ChiCTR-OCH-13003992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OCH-13003992.